MC
GEHC icon

Martin & Co’s GE HealthCare GEHC Stock Holding History

Martin & Co’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.34M Buy
52,218
+350
+0.7% +$23K 0.52% 62
2026
Q1 		$3.69M Buy
51,868
+757
+1% +$59.7K 0.63% 47
2025
Q4 		$4.19M Buy
51,111
+1,836
+4% +$143K 0.72% 38
2025
Q3 		$3.7M Sell
49,275
-226
-0.5% -$16.9K 0.66% 45
2025
Q2 		$3.67M Sell
49,501
-36
-0.1% -$2.51K 0.67% 40
2025
Q1 		$4M Buy
49,537
+423
+0.9% +$36.4K 0.77% 35
2024
Q4 		$3.84M Sell
49,114
-2,152
-4% -$183K 0.95% 37
2024
Q3 		$4.81M Buy
51,266
+67
+0.1% +$5.62K 1.13% 26
2024
Q2 		$3.99M Sell
51,199
-2,040
-4% -$166K 1% 34
2024
Q1 		$4.84M Sell
53,239
-350
-0.7% -$29.1K 1.18% 26
2023
Q4 		$4.14M Buy
53,589
+23,261
+77% +$1.63M 1.02% 30
2023
Q3 		$2.06M Sell
30,328
-230
-0.8% -$16.7K 0.54% 67
2023
Q2 		$2.48M Buy
+30,558
New +$2.44M 0.63% 55

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Martin & Co's GEHC Position: Q2 2026 in Review

Martin & Co increased its GE HealthCare (GEHC) stake by 0.67% in Q2 2026, buying an estimated $23K and bringing the position to 52,218 shares worth $3.34M. The position accounts for 0.52% of the portfolio, ranked #62.

Martin & Co first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.84M in Q1 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Martin & Co held 52,218 shares of GE HealthCare worth $3.34M as of Q2 2026.
  • Martin & Co bought 350 GE HealthCare shares in Q2 2026, an estimated $23K.
  • GE HealthCare made up 0.52% of Martin & Co's portfolio in Q2 2026, its #62 holding.
  • Martin & Co first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • Martin & Co's GE HealthCare position peaked at $4.84M in Q1 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Martin & Co's 13F filing for Q2 2026, filed 12 Aug 2026.